Announcements Call for applications by The Migration Health South Asia Network for skill & capacity development training workshop to be held in 6-9 April 2020   |   Open Letter: Stop the war on Syria’s hospitals

Are all new drugs ‘healthy’?

Sujith J Chandy, Atiya R Faruqui

DOI: 10.20529/IJME.2004.006


The race for the launch of new drugs, brands and combination drugs has resulted in nearly 50–80 new entries in the market in the year 2002 alone. Is it ‘healthy’ to have such a flooding of the market with new drugs? Do these new drugs really have benefits over their older congeners as most of them claim to have? To answer these questions, we need to look at two important aspects in the field of new drug marketing: safety and claims of superiority.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US